ABT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Abbott Laboratories's quarterly accounts payable declined from Sep. 2014 ($5,520 Mil) to Dec. 2014 ($5,415 Mil) but then increased from Dec. 2014 ($5,415 Mil) to Mar. 2015 ($5,933 Mil).
Abbott Laboratories's annual accounts payable declined from Dec. 2012 ($10,890 Mil) to Dec. 2013 ($5,948 Mil) and declined from Dec. 2013 ($5,948 Mil) to Dec. 2014 ($5,415 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Abbott Laboratories Annual Data
Abbott Laboratories Quarterly Data